Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Paracel was a specialized bioinformatics company that developed high-performance computing solutions for genomic and proteomic data analysis. The company was best known for its GeneMatcher system, a hardware-accelerated platform designed to perform rapid sequence similarity searches and assembly of large-scale genetic data. Founded in 1992 as a spin-off from TRW Inc. and headquartered in Pasadena, California, Paracel's technology became a critical component for large-scale sequencing projects, including the Human Genome Project. Its proprietary architecture allowed for data processing speeds that far exceeded standard software solutions of the time. In 2000, the company was acquired by Celera Genomics for approximately $283 million to bolster its computational infrastructure for genomic discovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Paracel.